Transaction · 0001415889-25-001957

Farnum Rhonda

Farnum Rhonda, SVP, COMM, MA, reported an open-market or private sale at Theravance Biopharma, Inc. involving 4000.000000 shares for an estimated $36000.00. Reported holdings after the transaction were 309565.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SSVP, COMM, MA

TBPHTheravance Biopharma, Inc.

Filing timeJan 23

Trade dateJan 21, 2025

Filing · SECView on SEC

InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows

Price at filing

—

Pre-filing

1mo ago1w ago1d ago

Returns since

7d30d90d180d1y

TBPH price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards

TBPH since 2025-01-23Filed 589 days ago · 30 days of pre-filing context shaded

Loading…

Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative

Type: Sell
Identifier: 0001415889-25-001957
Transaction date: Jan 21, 2025
Shares: 4.00k sh
Estimated value: -$3.60M
Holdings after: 309k sh

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M

Direct Ownership 10b5-1 Detected

0score

Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

SVP, COMM & MEDICAL AFFAIRS

Officer YesDirector No10% NoOther No

Footnotes & amended

No footnotes recorded.

Original filing · 0001415889-25-001957

Related transactions

0 other filings

Same reporting owner

Recent company activity

0 recent txs

TBPH